Supplementary file - Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistamines: a randomized, controlled trial

Supplementary data for the publication by Leducq S. et al. Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistamines: a randomized, controlled trial. J Am Acad Dermatol 2019.本数据集为Leducq S.等人发表的学术论文的补充数据。该论文题为《甲氨蝶呤（methotrexate）附加治疗对比安慰剂（placebo）治疗对H1抗组胺药（H1-antihistamines）耐药的慢性自发性荨麻疹（chronic spontaneous urticaria）患者的疗效及安全性：一项随机对照试验（randomized, controlled trial）》，发表于2019年的《美国皮肤病学会杂志（Journal of the American Academy of Dermatology）》。